COVID 19 Vaccine – questions of safety and civil liability

The Medicines and Healthcare Regulatory Agency (“MHRA”) has given Pfizer-BioNTech’s COVID-19 mRNA Vaccine BNT162b2 temporary authorisation under regulation 174 of the Human Medicines Regulations 2012, which enables temporary authorisation to be granted in response to situations such as pandemics. In this blog, which is the first of a two-part series, Cressida Mawdesley-Thomas considers when there could be civil liability for an unlicensed vaccine. It also considers the conditions imposed by the MHRA for the granting of the temporary authorisation to Pfizer-BioNTech’s COVID-19 vaccine.

William Audland QC and Isaac Hogarth settle Spinal Epidural Haematoma Clinical Negligence Claim at JSM weeks before liability trial

William Audland QC and Isaac Hogarth of 12 King’s Bench Walk, instructed by Hugh Johnson of Stewarts successfully represented the claimant (“C”) in his claim against University College London Hospitals NHS Trust (“D”), weeks before the start of a trial on liability, achieving a settlement of £4.5 million at a video Joint Settlement Meeting (JSM).

COVID-19 and Clinical Negligence Claims

Here, Henry Charles, Michael Brace and Lizzie Boulden explain why they consider that COVID-19 related clinical negligence claims arising out of redeployed healthcare professionals are unlikely to succeed on the present law. This should provide considerable comfort to healthcare professionals who are not only bravely risking their lives, but who are also working in unfamiliar roles in the national effort to fight the pandemic.